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Items for this week’s EPI Update include: 
 
•         Zostavax (zoster Vaccine) 
•         Influenza vaccine review 2006 
•         What vaccines do you need? 
•         Breast Cancer Awareness Month - Reducing your risk  
•         Happy Halloween 
•         Meeting announcements and training opportunities 
 
Zostavax (zoster vaccine) 
Herpes zoster (HZ), commonly known as shingles or zoster, is a manifestation of the 
reactivation of varicella zoster virus (VZV), which as a primary infection produces 
chicken pox (varicella). Following initial infection, the virus remains latent in the dorsal 
root or cranial sensory ganglia until it reactivates, producing zoster. Shingles has a high 
burden of disease with over 1 million cases annually. Fifteen to 30 percent of people will 
develop shingles during their lifetime with the risk being greatest among 
immunosuppressed and the elderly. Because the nerves along the path become inflamed, 
shingles can also be painful. Pain that lasts for months after the rash has healed is called 
post herpetic neuralgia (PHN). For some people, this pain can be severe and chronic. 
 
On May 25, the Food and Drug Administration (FDA) licensed Zostavax, for use in 
people 60 years of age and older for the prevention of shingles. Zostavax is given as a 
single dose injection. In persons 60 years of age and older, the vaccine reduced the 
occurrence of shingles by about 50 percent. The vaccine was most effective in people 60-
69 years of age; 64 percent disease reduction. Among those who were vaccinated with 
Zostavax but who still developed shingles, the duration of pain was shorter. Use of the 
vaccine in people with prior history of shingles has not been studied. Zostavax is not 
indicated for the treatment of zoster or PHN.   
 
Influenza vaccine review 2006 
Influenza vaccine contains three virus strains, two type A viruses and one type B virus. 
The exact composition changes year to year. Inactivated influenza vaccine contains killed 
viruses. In contrast, the nasal spray contains live attenuated viruses. Although, whole-
virus vaccines are still used in some countries and are highly effective, in the United 
States only subviron, split, subunit, purified surface antigen vaccines are used. These 
vaccines retain the immunogenic properties of the viral proteins but are associated with 
greatly reduced reactogenicity. This language split, subunit has led to some provider 
confusion, thinking it was half of a 0.5 ml. dose. 
  
When determining influenza vaccine dosing, consider the following: 
 
1.     Age of the recipient; for children 6 months through 35 months, the dose is 0.25 
ml. 
2.     Previously unvaccinated children 6 months through 8 years of age (less than 9 
years old), should receive 2 doses of vaccine (inactivated one month apart, live-
attenuated 6 weeks apart). Dose of vaccine is dependent on the recipient’s age. A 
child 6 through 35 months should receive 0.25 ml. Persons 36 months (3 years 
old) and older should receive 0.5 ml. 
3.     Vaccine manufacturer, brands are licensed for specific ages, refer to the chart on 
the Web site below. 
  
For more information, visit www.cdc.gov/mmwr/preview/mmwrhtml/rr5510a1.htm#tab4 
 
What vaccines do you need? 
There is an easy and quick quiz for adults and adolescents on the National Immunization 
Programs web site that can serve as a guide for recommended vaccines. Once the quiz is 
complete you can print out individual recommendations and a talking points guide to take 
to your health care provider. Please visit www2.cdc.gov/nip/adultimmsched. 
 
Breast Cancer Awareness Month - Reducing your risk  
There are ways you can help lower your risk of breast cancer: 
 
• Control your weight and exercise. Make healthy choices in the foods you eat and 
the kinds of drinks you have each day. Stay active.  
• Know your family history of breast cancer. If you have a mother, sister, or 
daughter with breast cancer, ask your doctor what your risk is of getting breast 
cancer and how you can lower your risk.  
• Some women use hormone replacement therapy (HRT) to treat the symptoms of 
menopause. Ask your doctor about the risks and benefits of HRT and find out if 
hormone replacement therapy is right for you.  
• Limit the amount of alcohol you drink.  
• Get screened for breast cancer regularly. By getting the necessary exams, you can 
increase your chances of finding out early on, if you have breast cancer and 
increase your chances of long term survival.  
 
For more information, visit www.cdc.gov/cancer/breast/basic_info/facts.htm. 
 
Happy Halloween 
For many people, fall events like Halloween and Harvest Day are fun times to dress up in 
costumes, go trick-or-treating, attend parties, and eat yummy treats. These events are also 
opportunities to provide nutritious snacks, get physical activity, and focus on safety. 
Below are tips to help make the festivities fun and safe for trick-or-treaters and party 
guests. 
 
• Expecting trick-or-treaters or party guests?  
o Provide more nutritious treats for trick-or-treaters, such as individual 
packs of raisins, trail mix, and pretzels. For party guests, offer a variety of 
fruits, vegetables, and cheeses.  
o Use party games and trick-or-treat time as an opportunity for kids to get 
their daily dose of 60 minutes of physical activity.  
o Be sure walking areas and stairs are well-lit and free of obstacles that 
could result in falls.  
o Keep candle-lit jack-o’-lanterns and luminaries away from doorsteps, 
walkways, landings, and curtains. Place them on sturdy tables, keep them 
out of the reach of pets and small children, and never leave them 
unattended.  
o Remind drivers to watch out for trick-or-treaters and to drive safely. 
 
Follow these tips to help make the festivities fun and safe for everyone. For more 
information go to www.cdc.gov/women/owh/halloween. 
 
Meeting announcements and training opportunities: 
 
2006 – 2007 Influenza Update ICN: 
 
What: The 2006-2007 Influenza Update 
Where: Iowa Communication Network (ICN) 
When: 12:00 p.m. – 2:00 p.m. on Wednesday, Nov. 1 
Who: Iowa’s influenza surveillance clinicians, health care providers, 
laboratorians, public health practitioners and infection control professionals 
 
For more information, visit the University Hygienic Laboratory Web site at  
www.uhl.uiowa.edu/educationoutreach/conferencesevents/influenzaworkshop/ind
ex.xml. 
 
Teleconference for health care providers 
 
Nov. 9, 2006, 12:00 p.m. – 1:00 p.m. - “Seasonal Influenza, Antivirals and 
Clostridium difficile” (A call in telephone number will be provided following 
receipt of registration form) 
 
Philip M. Polgreen, M.D. 
Assistant Professor 
Department of Internal Medicine 
Division of Infectious Disease 
University of Iowa 
 
Objectives:  
o To discuss clinical aspects of seasonal influenza, including vaccine and 
antivirals.  
o To understand the connection of Clostridium difficile to antibiotic use and 
seasonal influenza. 
For a registration form, visit  
www.idph.state.ia.us/adper/common/pdf/cade/grandround_2006_registration.pdf.  
  
Tuberculosis: Diagnosed in 24 Hours 
 
Tuesday November 14, 2006 
Audio Conference 
12-1 p.m. 
Fee: Free for Iowa residents 
Register online at: http://www.nltn.org/009-06 
If difficulties registering call 240-485-2727 or email registrart@aphl.org 
 
 
 
Have a healthy and happy week! 
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Iowa Department of Public Health 
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